BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/15/2022 11:41:26 AM | Browse: 625 | Download: 1819
 |
Received |
|
2022-08-17 15:33 |
|
Peer-Review Started |
|
2022-08-10 13:56 |
|
First Decision by Editorial Office Director |
|
2022-10-05 06:50 |
|
Return for Revision |
|
2022-10-05 06:50 |
|
Revised |
|
2022-10-18 15:44 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-12-01 03:25 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-12-01 22:39 |
|
Articles in Press |
|
2022-12-01 22:39 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-12-06 00:35 |
|
Publish the Manuscript Online |
|
2022-12-15 11:41 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, General & Internal |
| Manuscript Type |
Observational Study |
| Article Title |
Baseline moderate-range albuminuria is associated with protection against severe COVID-19 pneumonia
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Amir Bashkin, Mona Shehadeh, Lina Shbita, Kamil Namoura, Ronza Haiek, Elena Kuyantseva, Yousef Boulos, Orly Yakir and Etty Kruzel-Davila |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Amir Bashkin, MD, Director, Director, Doctor, Doctor, Researcher, Department of Diabetes, Endocrinology, and Metabolism, Galilee Medical Center, Route 89, Nahariya 2210001, Israel. amirb@gmc.gov.il |
| Key Words |
Diabetes mellitus; COVID-19; Albuminuria; Severity; Chronic kidney disease; Immunomodulation |
| Core Tip |
Type 2 diabetes mellitus and its risk factors are considered to be contributors to severe coronavirus disease 2019 (COVID-19). In this study, we analyzed our single-center clinical data of adults with type 2 diabetes between September 2020 and May 2021 to determine the impact of risk factors on severity of COVID-19 pneumonia. Surprisingly, we found that moderate-range pre-hospitalization albuminuria was associated with reduced risk of severe COVID-19 pneumonia. Further studies are needed to explore this association and pathogenesis relating to immunomodulation, which may indicate a biomarker for patients at reduced risk for COVID-19-related deterioration that may translate to therapeutic interventions. |
| Publish Date |
2022-12-15 11:41 |
| Citation |
Bashkin A, Shehadeh M, Shbita L, Namoura K, Haiek R, Kuyantseva E, Boulos Y, Yakir O, Kruzel-Davila E. Baseline moderate-range albuminuria is associated with protection against severe COVID-19 pneumonia. World J Diabetes 2022; 13(12): 1154-1167 |
| URL |
https://www.wjgnet.com/1948-9358/full/v13/i12/1154.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v13.i12.1154 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
